Fate Therapeutics, Inc. (NASDAQ:FATE) Q2 2023 Earnings Call Transcript

Fate Therapeutics, Inc. (NASDAQ:FATE) Q2 2023 Earnings Call Transcript August 8, 2023

Fate Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.54, expectations were $-0.58.

Operator: Welcome to the Fate Therapeutics Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in listen-only mode. This call is being webcast live on the Investors section of Fate’s website at fatetherapeutics.com. As a reminder, today’s call is being recorded. I...